Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (equine epithelium extract); allergen extracts 1 ic/ml (equine epithelium extract); allergen extracts 10 ic/ml (equine epithelium extract) - solution for injection - active: allergen extracts 0.1 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (rumex acetosa pollen extract); allergen extracts 1 ic/ml (rumex acetosa pollen extract); allergen extracts 10 ic/ml (rumex acetosa pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - american house dust mite extract, quantity: 5 ir/ml; european house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; water for injections; aluminium hydroxide hydrate; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite extract, quantity: 5 ir/ml; american house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; phenol; sodium chloride; water for injections; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 601.2 mg/g (equivalent: protease, qty 2000 ph eur unit; equivalent: amylase, qty 36000 ph eur unit; equivalent: lipase, qty 50000 ph eur unit) - granules, enteric-coated - excipient ingredients: hypromellose phthalate; cetyl alcohol; dimeticone 1000; macrogol 4000; triethyl citrate - creon micro is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 150 mg (equivalent: amylase, qty 8000 ph eur unit; equivalent: lipase, qty 10000 ph eur unit; equivalent: protease, qty 600 ph eur unit) - capsule, enteric - excipient ingredients: iron oxide yellow; sodium lauryl sulfate; macrogol 4000; iron oxide black; triethyl citrate; titanium dioxide; cetyl alcohol; dimeticone 1000; gelatin; iron oxide red; hypromellose phthalate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)